Data / Form D filings / Regenicin, Inc.
Regenicin, Inc.: Form D filings
Regenicin, Inc., a health care company in New York, NY, filed 2 Form D notices with the SEC in 2010. The latest, on October 18, 2010, reports an offering of $3.5 million with nothing sold yet.
Find out what Regenicin, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 470 PARK AVENUE SOUTH 16TH FLOOR, New York, NY, 10010
- Phone
- (212) 518-8474
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2007
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1412659
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 18, 2010 | New notice | $3,500,000 | $0 | $3,500,000 | 0 | Yet to occur | sec.gov |
| Aug 2, 2010 | New notice | $4,500,000 | $0 | $4,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Randall McCoy | Executive Officer, Director | |
| John J. Weber | Executive Officer, Director | |
| Joseph J. Rubinfeld | Director | |
| Chris J. Hadsall | Executive Officer | |
| Joseph Connell | Executive Officer | |
| Craig J. Eagle | Director |
Other health care companies in New York that filed recently
- NextVein LLC $1.2 million · Nov 3, 2026
- MOCEAN HOLDINGS Corp $1.5 million · Oct 27, 2026
- Frictionworx Inc. $40,000 · Oct 13, 2026
- Atmos Clinic, Inc. $6 million · Oct 8, 2026
- PreciseDx, Inc. $3.7 million · Oct 7, 2026
- Amani Therapeutics, Inc. $35 million · Oct 1, 2026
- Click Therapeutics, Inc. $50 million · Oct 1, 2026
- FRONTIER MEDTECH FUND I, L.P. $80,000 · Sep 29, 2026
- Emmi Health, Inc $20,000 · Sep 28, 2026
- Precision Neuroscience Corp $250 million · Sep 28, 2026
- AmorSui Inc. $2.7 million · Sep 23, 2026
- Light Wave Holding Company, LLC $1 million · Sep 22, 2026
- INTELLIGENT BIO SOLUTIONS INC. $5 million · Sep 14, 2026
- Rightway Healthcare, Inc. $155 million · Sep 8, 2026
- Brilliskin, Inc. $25,000 · Aug 31, 2026
Every Form D from the week of Oct 18, 2010 · All recent filings in New York · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Regenicin, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.